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Background: Sepsis is now the leading cause of death in the non-cardiovascular intensive care unit (ICU). Recent
research suggests that sepsis is likely to be due to an interaction between genetic and environmental factors.
Genetic mutations of toll-like receptor 4 (TLR4) and cluster of differentiation 14 (CD14) genes are involved in the
immune and (or) inflammatory response. These may contribute to the susceptibility to sepsis in patients. This study
was designed to evaluate whether the TLR4 and cluster CD14 gene polymorphisms are associated with susceptibility
to sepsis.
Methods: The single nucleotide polymorphisms (SNPs) of TLR4 (rs10759932, rs11536889, rs7873784, rs12377632,
rs1927907, rs1153879) and CD14 (rs2569190 and rs2563298) in patients with sepsis and control subjects in the
Guangxi Province were analyzed by using the polymerase chain reaction-single base extension (PCR-SBE) and DNA
sequencing methods.
Results: The rs11536889 polymorphism in TLR4 and rs2563298 polymorphism in CD14 were significantly associated
with the risk of sepsis when compared to the control group. The frequencies of rs11536889 and rs2563298
polymorphisms in the group with sepsis were higher than that in the control group (OR = 1.430, 95% CI, 1.032-1.981,
P<0.05; OR = 2.454, 95% CI, 1.458-4.130, P<0.05, respectively). Followed up haplotype analysis suggested that there were
two haplotypes in which increased risk factors for sepsis were indicated.
Conclusions: The rs11536889 polymorphism in TLR4 and rs2563298 polymorphism in CD14, and two haplotypes were
associated with increased susceptibility to sepsis.
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Sepsis is a clinical, catastrophic condition whereby patho-
genic microorganisms are able to trigger in the host,
the immune and coagulation systems as well as apoptosis
which result in systemic inflammatory response syndrome
(SIRS). In response to infection, increased amounts of
proinflammatory and antiinflammatory mediators are re-
leased. The imbalance between proinflammatory and anti-
inflammatory effectors may lead to cell and tissue injury* Correspondence: liaopinhu@163.com
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unless otherwise stated.as well as organ function disorder, which can results in a
series of serious medical complications [1].
Despite significant advances in intensive care, improved
supportive measures and popularized evidence-based
guidelines, the prognosis for sepsis is still not ideal,
and severe sepsis and septic shock are also the leading
causes of death in the non-cardiovascular intensive care
unit, even in developed countries [2].
Patients with similar general clinical symptoms and in-
fected with the same microorganisms and undergoing simi-
lar therapy could present with different clinical outcomes,
which indicate that genetic factors may be involved in these
processes [3,4]. Research evidence suggests that sepsis
is likely to be due to an interaction of genetic andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 The clinical characteristics of the study subjects
Parameters Cases (n = 152) Controls (n = 199)
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http://www.biomedcentral.com/1471-2350/15/123environmental factors [5-7]. Genetic factors may affect
the body’s response to infection caused by microorgan-
isms. Genetic mutation in genes involved in the im-
mune and (or) inflammatory response may contribute
to the susceptibility to sepsis [6]. This may explain the
clinical variability observed during similar infections.
The infection-triggered systemic inflammatory response
plays a critical role in the pathogenesis of sepsis [8,9]. The
immune response is the first-line response to defense mi-
crobial infections. Pattern recognition receptors (PRRs)
are essential for triggering the immune response and
these include the TLR gene family. These receptors can
recognize molecules expressed on the surface of micro-
organisms, which are called pathogen-associated molecu-
lar patterns (PAMPs). It is postulated that SNPs in these
receptors may influence their ability to recognize microor-
ganisms [10].
TLRs are an evolutionarily conserved family of receptors
which play fundamental roles in pathogen recognition and
the innate immune and inflammatory response [11-14].
TLRs have three functional domains within their struc-
tures: an ectodomain, which contains multiple leucine-
rich repeats (LRR) participating in the recognition and
binding of pathogens, a cytoplasmic domain that also
spans the membrane and a toll/interleukin-1 receptor
(TIR) domain. To date thirteen members of the TLR
family have been identified [15]. TLR4 is one of the TLR
family members that has been the widely most investi-
gated. The gene encoding for human TLR4 is mapped
on chromosome 9q32-33 and includes 3 exons and 2 in-
trons. TLR4 can recognize a variety of pathogens, in-
cluding Gram-negative and Gram-positive bacteria [16],
fungi [17], viruses [18] and protozoa [19]. CD14 is a cor-
eceptor that contributes to TLR-induced cell activation.
Upon binding to the microbial ligands, CD14 becomes
linked to TLR4 and then, TLR4 can activate downstream
signaling transduction pathways, such as the nuclear
factor-kappa B (NF-κB) signaling pathway. This subse-
quently mediates the production of cytokines, chemo-
kines and coagulation factors which are involved in the
pathological process of inflammation [12,20].
It has been reported that some polymorphisms in the
TLR4 and CD14 genes may regulate their expression,
thereby, influencing the production of TLR4 [21] and
CD14 [22,23]. Several studies have shown that poly-
morphisms in TLR4 and CD14 genes may relate to the
susceptibility with some infection induced diseases, e.g.
sepsis [24-28], but this is controversial.
In this study, we investigated the relationship between
sepsis and TLR4 gene rs10759932, rs11536889, rs7873784,
rs12377632, rs1927907 and rs1153879 polymorphisms
as well as CD14 gene rs2563298 and rs2569190 polymor-
phisms in a Chinese population. Genotyping analysis of
eight SNPs in TLR4 and CD14 genes were performed byusing Snapshot SNP genotyping assays and DNA sequen-
cing methods to investigate whether the gene polymor-
phisms are associated with susceptibility to sepsis.
Methods
Study subjects
The clinical characteristics of the study subjects are
shown in Table 1. One hundred and fifty-two patients
(48 females and 104 males) from the ages of 18 to
80 years (average age-55.47 ± 16.48) with sepsis were re-
cruited for this study between July 2011 and December
2012 in the ICU of the Affiliated Hospital of Youjiang
Medical University for Nationalities, Guangxi, PR China.
The inclusion criteria were according to the American
College of Chest Physicians/Society of Critical Care
Medicine (ACCP/SCCM) criteria for sepsis, severe sep-
sis, or septic shock. Exclusion criteria were: 1. patients
younger than 18 or older than 80 years old; 2. cardiac ar-
rest; 3. emergency surgery; 4. receiving an immunosup-
pressive therapy. In addition, patients from whom
consent could not be obtained were excluded from the
study.
The control subjects underwent a routine medical
check-up in the outpatient clinic of the Department of
Internal Medicine, Affiliated Hospital of Youjiang Medical
University for Nationalities, Guangxi, China between July
2011 and December 2012. According to the thorough
clinical and laboratory evaluation, none of them was
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tion, history of cardiac arrest or receiving an immuno-
suppressive therapy. One hundred and ninety-nine
control subjects from similar ethnic background, age
and gender (81 females and 118 males, aged between
25 and 80 years) were also studied. The protocol used
for the study was approved by the Local Ethical Committee
of Youjiang Medical University of Medical Sciences, and
written informed consent was obtained from all partici-
pants. All participating subjects were of Guangxi origin.DNA extraction and PCR assay
5 mL of venous blood was collected from each patient
for genetic studies. Genomic DNA was extracted from
whole peripheral blood using a QIA Amp DNA Blood
Mini Kit (Qiagen, Germany) according to the standard
protocols. The DNA was subsequently stored at −20°C
until needed. Before use, the DNA was resolved using a
1% agarose gel stained with the ethidium bromide.Table 2 The primer sequences used for detecting the differen



























F: forward, R: reverse, E: extension.The following sequences obtained from GenBank were
used as reference sequences for TLR4 (Gene ID: 7099):
NG_011475.1: 4994–18310 (genomic) and CD14 (Gene
ID: 929): NG_023178.1: 5001–6974 (genomic). PCR
primers were designed using Primer 3 Input (version
0.4.0; Table 2). The PCR reactions consisted of 1x HotStart
Taq buffer, 3.0 mM magnesium chloride, 0.3 mM dNTP
mixture, 1 U HotStart Taq polymerase, forward and reverse
primer mixtures and genomic DNA. The PCR conditions
were as follows: 95°C for 2 min, followed by 11 cycles of:
94°C for 20 sec, annealing temperature depending on the
primer, 72°C for 90 sec, 24 cycles of: 94°C for 20 sec, 59°C
for 30 sec, 72°C for 90 sec, and then 72°C for 2 min
followed by 4°C until the reaction mixtures were removed
from the cycler.
Genotyping procedure
PCR products were sequenced using the ABI PRISM
SNaPshot Multiplex Kit according to the protocols.
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Mapper 4.1 (Applied Biosystems Co., Ltd., USA).
Statistical analysis
Quanto software was used to estimate the adequate sam-
ple size for our study. The relative risk was set to 1.30
and the statistical power was more than 80%. Demo-
graphic and clinical data between sepsis cases and con-
trols were compared by chi-square test (χ2 test) and by
Student's t-test. The differences in genotype and allele
frequencies of TLR4 and CD14 were compared among
the groups using the χ2 test and when appropriate, Fisher’s
exact test (two-sided analysis) was used as indicated. Odds
ratios (OR) and 95% confidence intervals (CIs) were calcu-
lated to assess the relative risk conferred by a particular al-
lele and genotype. Hardy-Weinberg equilibrium analysis
was tested by comparing the detected genotype distribu-
tion with the theoretical distribution estimated on the basis
of the allele frequencies in the control group (Table 3). The
linkage disequilibrium (LD) among SNPs of the TLR4 gene
or the CD14 gene was examined by pair-wise comparisons
of D’ using Haploview, version 4.1. The haplotypes and
their frequencies were estimated based on a Bayesian algo-
rithm using the Phase program [29]. No correction for
multiple testing was performed during analysis of the data.
All reported p values were two-tailed and p <0.05 was
considered to be significant. The SPSS statistical software
package version 13.0 was used for statistical analysis.Table 3 Hardy-Weinberg equilibrium analysis
Polymorphism Actual distribution T
Genotypes G
TLR4
CC CT TT C
rs10759932(T/C) 7 62 130 7
AA GA GG A
rs12377632(C/T) 19 94 86 2
CC CT TT C
rs1927907(C/T) 136 47 5 1
AA GA GG A
rs11536879(A/G) 145 48 3 1
CC GC GG C
rs11536889(G/C) 15 75 109 1
CC CG GG C
rs7873784(G/C) 2 39 157 2
CD14
AA GA GG A
rs2569190(A/G) 65 87 45 5
AA CA CC A
rs2563298(C/A) 4 53 141 4Results
One hundred fifty-two patients with sepsis and one hun-
dred ninety-nine control subjects were genotyped. The
genotypic and allelic frequencies for SNPs are shown in
Table 4. The frequency of all genotypes studied did not
reveal any difference using the Hardy-Weinberg equilib-
rium analysis in control groups (p > 0.05).
As shown in Table 4, a statistical significance was ob-
served between rs11536889 in TLR4 gene and rs2563298
in CD14 gene in patients with sepsis and controls. The
genotype frequency of rs11536889 indicated a trend of
higher frequency of GC + CC in the sepsis patients
(p = 0.009<0.05), [OR and 95% CI: 1.758(1.147-2.695)]. The
C allele was significantly associated with susceptibility to
sepsis (p = 0.031<0.05) [OR and 95% CI: 1.430 (1.032-
1.981)]. Compared to healthy controls, the rs2563298 was
significantly associated with a risk of sepsis, and the fre-
quencies of the CC, CA and AA genotypes of rs2563298
were 86.8%, 12.5% and 0.7% in cases of sepsis and were
71.2%, 26.8% and 2.0% in control subjects, respectively.
The C allele was associated with a significantly increased
risk of sepsis as compared with the A allele (p = 0.001<0.05)
[OR and 95% CI: 2.454 (1.458-4.130)].
Figure 1 shows the pair-wise LD of the SNPs of TLR4
and CD14 genes in patients with sepsis. The haplotype
frequency of the eight SNPs of TLR4 gene and two SNPs
of CD14 gene were estimated. For the TLR4 gene, there
were eleven SNP haplotypes detected, and only four hadheoretical distribution χ2 P
enotypes
C CT TT
.26 61.49 130.26 0.014 0.993
A GA GG
1.89 88.22 88.89 0.854 0.653
C CT TT
35.32 48.36 4.32 0.148 0.928
A GA GG
45.72 46.56 3.72 0.187 0.911
C GC GG
3.85 77.30 107.85 0.176 0.916
C CG GG
.33 38.33 157.33 0.060 0.970
A GA GG
9.76 97.48 39.76 2.279 0.320
A CA CC
.70 51.60 141.70 0.145 0.930
Table 4 The genotype and allele frequencies of patients with sepsis and controls
Polymorphism Genotypes χ2 P Alleles OR(95% CI) P
11 12 22 1 2
TLR4
rs10759932(T/C) TT TC CC T C
Controls 130 62 7 0.987 0.611 322 76 0.874(0.592-1.290) 0.499
Cases 106 40 6 252 52
rs12377632(C/T) CC CT TT C T
Controls 86 94 19 0.433 0.805 266 132 0.916(0.665-1.261) 0.591
Cases 71 67 14 209 95
rs1927907(C/T) CC CT TT C T
Controls 136 47 5 0.499 0.802 319 57 1.075(0.710-1.630) 0.732
Cases 109 37 6 255 49
rs11536879(A/G) AA AG GG A G
Controls 145 48 3 0.756 0.72 338 54 1.031(0.670-1.588) 0.889
Cases 110 41 1 261 43
rs11536889(G/C) GG GC CC G C
Controls 109 75 15 6.918 0.031 293 105 1.430(1.032-1.981) 0.031
Cases 62 77 13 201 103
rs7873784(G/C) GG GC CC G C
Controls 157 39 2 0.616 0.752 353 43 1.173(0.737-1.866) 0.501
Cases 116 34 2 266 38
CD14
rs2569190(A/G) AA AG GG A G
Controls 65 87 45 3.973 0.137 217 177 1.322(0.975-1.793) 0.073
Cases 58 72 22 188 116
rs2563298(C/A) CC CA AA C A
Controls 141 53 4 12.41 0.001 335 61 2.454(1.458-4.130) 0.001
Cases 132 19 1 283 21
No correction for multiple testing was performed during analysis of the data.
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the results indicate that one haplotype (TACCCG) con-
tributed to a significant difference (p = 0.006<0.05) [OR
and 95% CI: 1.590 (1.143-2.211)], which therefore shows
that this haplotype serves as an increase risk factor for
sepsis. The other haplotypes were not associated with
susceptibility to sepsis. As for the CD14 gene, there
were four SNP haplotypes detected (Table 6). Compared
to controls, the haplotype AG was significantly different
(p = 0.001<0.05) [OR and 95% CI: 0.410 (0.244-0.690)],
and this seems to provide a protective role in sepsis.
Discussion
In this study, we investigated the association of TLR4
gene and CD14 gene SNPs (TLR4: rs10759932, rs11536889,
rs7873784, rs12377632, rs1927907, rs1153879 and CD14:
rs2563298, rs2569190) with susceptibility to sepsis. Our
results demonstrate that statistically significant associationswith risk of sepsis were observed for the candidate
rs11536889 SNP of TLR4 gene, rs2563298 SNP of CD14
gene and two haplotypes.
TLR4 is a type I transmembrane protein which plays a
key role in host defense mechanisms by activating both
innate and adaptive immunity against pathogenic micro-
bial infections such as Escherichia coli, Klebsiella pneumo-
niae, Staphylococcus aureus, Acinetobacter baumannii and
Pseudomonas aeruginosa [30,31]. It plays an important
role in some immune and inflammatory diseases. Several
studies have reported a functional significance of TLR4
gene polymorphisms. Previous studies had reported that
two SNPs of the TLR4 gene, which are located in promoter
region, could lead to hyporesponsiveness to lipopolysac-
charide (LPS) [32,33]. The possible involvement of these
SNPs in the development of sepsis has been widely re-
ported [17,24,25,34]. However, the distribution of these
SNPs is rare in the Chinese [35,36] as well as in the general
Figure 1 Linkage disequilibrium plot of six SNPs of the TLR4 gene in patients with sepsis. D’ corresponding to each SNP pair is expressed
as a percentage and shown within the respective squares. Higher D’ is indicated by a brighter red colour.
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GC +CC genotype rs11536889, which is located in the 3’-
untranslated region, is higher in the sepsis group when
compared to the controls. With the present study, there is
no evidence that rs10759932, rs7873784, rs12377632,
rs1927907 and rs1153879 are associated with susceptibility
to sepsis. By haplotype analysis, it was found that the
TACCCG haplotype was associated with a significantly
increased risk of sepsis when compared with the control
group.
Fukusaki et al. [37] suggested that CC genotype
rs11536889 was associated with moderate and severeTable 5 Haplotype distribution of TLR4 in patients with
sepsis and controls
Haplotypes Cases Controls χ2 P OR (95%)
CATTGG 49 55 0.722 0.395 1.198(0.789-1.820)
TACCCG 103 97 7.651 0.006 1.590(1.143-2.211)
TACCGG 104 152 1.179 0.278 0.842(0.616-1.149)
TGTCGC 36 38 0.962 0.327 1.273(0.785-2.062)
TGTCGG 7 13 0.578 0.447 0.698(0.275-1.771)
CATCCG 0 1 - - -
CATCGG 3 10 - - -
CATTCG 0 0 - - -
TACCGC 2 1 - - -
TATCGG 0 1 - - -
TGTCCC 0 0 - - -
From left to right: rs10759932 T/C; rs11536879 A/G; rs12377632 C/T; rs1927907
C/T; rs11536889 G/C and rs7873784 G/C.periodontitis in the Japanese population. Hishida et al.
[38,39] have shown that GC + CC genotype rs11536889
may be associated with severe gastric atrophy related
to Helicobacter pylori infection. Zhou et al. [40] exam-
ined whether polymorphisms of the TLRs genes were
associated with hepatitis B virus recurrence after liver
transplantation. They showed a significant association
of one SNP, namely rs11536889, with hepatitis B virus
recurrence after liver transplantation. Hepatitis B virus
recurrence after liver transplantation was higher than in the
patients with the CC genotype when compared to other ge-
notypes. Miedema et al. [41] found that rs11536889 poly-
morphism may be associated with an increased risk of
developing chemotherapy-induced neutropenia. Sato et al.
[21] investigated whether polymorphisms of rs11536889
were associated with expression or function of TLR4. They
found that TLR4 mRNA expression in PBMCs among
GG, GC and CC genotypes did not significantly respond
to LPS stimulation. However, the TLR4 protein expressed
at the cell surface membrane was different. Therefore, it
is possible that the G allele of rs11536889 may inhibitTable 6 Haplotype distribution of CD14 in patients with
sepsis and controls
Haplotypes Cases Controls χ2 P OR(95%)
AG 21 61 11.841 0.001 0.410(0.244-0.690)
CA 188 217 3.783 0.052 1.252(0.997-1.832)
CG 95 116 0.363 0.547 1.105(0.798-1.529)
AA - - - - -
From left to right: rs2569190 A/G and rs2563298 C/A.
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regulate the expression of the TLR4 gene. Meanwhile,
this study shows that certain genotypes may affect the
release of inflammatory cytokines. As shown by Mansur
et al., polymorphism of rs11536889 can affect the clinical
outcome of patients with sepsis. In addition, the G allele of
rs11536889 may increase the incidence of gram-negative
infections [42].
CD14 is also an important recognition receptor which
plays a key role in the immune and inflammatory re-
sponses. Previous studies have shown that polymorphisms
of CD14 gene are involved with some inflammatory dis-
eases, such as asthma [43], inflammatory bowel disease
[44,45], ulcerative colitis [44] and Crohn's disease [46].
Currently, most studies focused on the SNPs which were
located within CD14 gene promoter region. Results from
previous studies have shown that these SNPs were associ-
ated with the prognosis of critically ill patients [47,48].
Studies have shown that genetic polymorphisms of these
SNPs can affect CD14 gene expression as well as the level
of soluble CD14 in serum [22,23], and that this might be
involved with the occurrence of sepsis and the subsequent
prognosis of the disease [26,28]. However, these studies
are not consistent. One meta-analysis evaluated the asso-
ciated between CD14 promoter -159C/T polymorphism
and the risk of sepsis. The results demonstrated that this
SNP is unlikely to be a risk factor for susceptibility to sep-
sis. Only a weak correlation was found in the Asian popu-
lation [27]. This study also illustrates the importance of
genetic background and environmental factors in estab-
lishing whether SNPs may be risk factors for susceptibility
to sepsis.
Our results suggest that there is no evidence that
rs2569190 is associated with susceptibility to sepsis. Com-
pared to the control group, CC genotypes of rs2563298 in
the sepsis group were significantly higher and the fre-
quency of C allele in the sepsis group was also significantly
higher. By haplotype analysis, it was found that the AG
haplotype may be a protective factor to sepsis. Rs2563298
is located in the 3’-untranslated region of the CD14 gene.
This study is the first to assess the potential implications
of CD14 gene rs2563298 on susceptibility to sepsis. Previ-
ous studies suggested that SNPs in the 3’-untranslated re-
gion may have an important role in mRNA translation.
Liu et al. [49] suggested that CD14 genetic polymor-
phisms may affect the length of CD14 transcripts or the
efficiency protein translation, which could influence the
function of CD14 and lead to a dysregulation of the im-
mune response.
SNPs in the 3’-untranslated region probably have no
direct effect on the primary structure (ie. amino acid se-
quence) of the protein. But the SNPs may change the
function of 3’-end of mRNA or affect the mRNA stability
in order to regulate target gene expression which may, inturn, affect the process of transmembrane conductance
signals.
The observed association of higher susceptibility to
sepsis among TLR4 rs11536889 and CD14 rs2563298
genotypes may help intensive care specialists to identify
patients at risk of developing sepsis.
Conclusions
In summary, this study indicates that SNPs (TLR4: rs
11536889 and CD14: rs2563298) and two haplotypes
are associated with susceptibility to sepsis in a Chinese
population.
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